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Background: In recent years, several clinical cases and epidemiological studies of feline vector-borne diseases
(FVBD) have been reported worldwide. Nonetheless, information on FVBD agents and their prevalence in Portugal is
scarce.
Methods: Three-hundred and twenty domestic cats presented to 30 veterinary medical centres in the north and
centre regions of Portugal were randomly sampled. Blood was assayed by real-time polymerase chain reaction
(PCR) for genera Anaplasma/Ehrlichia, genus Babesia, Hepatozoon canis, Hepatozoon felis, Leishmania infantum and
the genus Rickettsia. Babesia-positive samples were further tested for Babesia canis and Babesia vogeli.
Results: Eighty (25.0%) out of the 320 cats were positive to at least one vector-borne agent, including seven (2.2%)
cats co-infected with two agents. Two cats (0.6%) were infected with Anaplasma/Ehrlichia spp., four (1.3%) with B.
canis, 26 (8.1%) with B. vogeli, 50 (15.6%) with H. felis, one (0.3%) with L. infantum and four (1.3%) with Rickettsia spp.
No cat tested positive for H. canis. One cat (0.3%) was co-infected with B. canis and B. vogeli, three (0.9%) with B.
vogeli and H. felis, one (0.3%) with H. felis and L. infantum, and two (0.6%) with H. felis and Rickettsia spp.
Conclusions: A considerable prevalence of infection with vector-borne pathogens among the domestic feline
population of the north and centre of Portugal has been revealed by the present study. Additionally, this is the first
detection of B. vogeli in cats from Europe and of H. felis in cats from Portugal.
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Vector-borne diseases compromise a variety of infectious
illnesses caused by several agents, including viruses, bac-
teria, protozoa and helminthes, which are transmitted by
ticks, fleas, mosquitoes and phlebotomine sand flies
[1,2]. Many of these agents are emerging or re-emerging
pathogens [3] and some of them are of zoonotic concern
[4,5]. The frequency of some vector-borne diseases is in-
creasing in Europe, partially due to climatic alterations
that have a direct impact on the abundance, geograph-
ical distribution and vectorial capacity of arthropod vec-
tors, but also due to the increased mobility of human* Correspondence: lcardoso@utad.pt
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reproduction in any medium, provided the orbeings and animals, which further promote the circula-
tion and exchange of vectors and infectious agents
[1,3,6,7].
Although several vector-borne agents cause morbidity
and mortality in the domestic feline population [8], the
importance of some of them as a cause of disease has
not yet been clearly determined [9]. This lack of know-
ledge, associated with the unawareness of the distribu-
tion and ecology of feline vector-borne diseases (FVBD)
of zoonotic concern, has impaired the implementation
of effective control measures to prevent infection of cats,
other animals and human beings [1].
The diagnosis of infectious diseases in cats may be
challenging, as some infections can occur in healthy cats
[10], and whenever present clinical signs are frequently
non-specific [1,11]. Most of the agents are often present
in low numbers in peripheral blood, are difficult to culti-
vate in vitro, elicited specific antibody responses may beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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exist between some organisms [12]. Many problems of
serology are circumvented by the use of the polymerase
chain reaction (PCR) [12,13]. In addition to accurate de-
tection of infectious agents in animals, human beings
and arthropod vectors, DNA-based techniques allow
species characterization of different pathogens, which
can be important for treatment and prognosis [6]. Com-
pared with the conventional method, real-time PCR can
have a higher sensitivity in some diseases [14] and is a
useful tool both for diagnosis and treatment monitoring
[13].
Previous clinical case reports [15], and serological or
molecular surveys [16-19] have described infection with
different vector-borne organisms in cats from Portugal.
Nonetheless, information about agents of FVBD and
their prevalence in Portugal is scarce. The aims of the
present study were to identify the presence and preva-
lence of vector-borne agents from genera Anaplasma,
Babesia, Ehrlichia, Hepatozoon, Leishmania and Rickett-
sia in cats from the north and centre regions of
Portugal, by means of real-time PCR, and to identify risk
factors associated with infection.Methods
Cats and samples
Three-hundred and twenty domestic cats from the north
(n = 140) and centre (n = 180) of Portugal were randomly
sampled in 30 veterinary medical centres, without inclu-
sion/exclusion criteria or pre-established minima/maxima.
The number of cats sampled per centre ranged from 1 to
58. This study was ethically approved by the board of the
University of Trás-os-Montes e Alto Douro veterinary
teaching hospital as complying with the Portuguese legis-
lation for the protection of animals (Law no. 92/1995,
from September the 12th).
Whole blood samples were obtained by jugular or
cephalic venipuncture into EDTA tubes and stored
at −20°C until DNA extraction. Whenever available,
medical and geographic data of each cat was collected,
including gender, age, breed, living conditions, clinical
status, and feline immunodeficiency virus (FIV)/feline
leukaemia virus (FeLV) infections status (Table 1).
Practitioners classified the cats as clinically suspect, if
they had clinical signs compatible with a FVBD, or
non-suspect, when they were apparently healthy or
had clinical signs not compatible with an infectious
disease. Compatible physical signs and clinicopatho-
logical abnormalities comprised anorexia, weight loss,
gastrointestinal alterations, anemia, thrombocytopenia,
leukocytosis or leukopenia, jaundice and dermato-
logical or ocular manifestations without any other
attributable aetiology.DNA extraction, PCR amplification and sequencing
DNA was obtained from 0.5 ml of peripheral blood, as
previously described [14].
Real-time quantitative (q) PCR for Leishmania
infantum was carried out according to the method de-
scribed by Francino et al. [14]. The targets of primers
(Table 2) and TaqMan-MGB probes were conserved re-
gions of the kinetoplastic minicircle of L. infantum.
For the other agents, samples were submitted to differ-
ent qPCR for genera Anaplasma/Ehrlichia, genus Babe-
sia, Hepatozoon canis, Hepatozoon felis and genus
Rickettsia. Babesia-positive samples were further tested
for Babesia canis and Babesia vogeli. All primers were
designed by The Molecular Genetics Veterinary Service,
(Universitat Autònoma de Barcelona) (Table 2). Specifi-
city of each primer was: (i) tested in silico, to avoid
cross-amplification with other FVBD agents, using se-
quence information available in Genbank and RDP II da-
tabases; and (ii) also validated by the amplification of the
positive control for which the PCR had been designed
and by the absence of amplification in samples positive
to other pathogens; and (iii) by DNA sequencing of
some positive samples to confirm agents B. canis (n = 1),
B. vogeli (n = 3) and H. felis (n = 4).
For all agents, qPCR amplification was carried out
in a final volume of 20 μl using FastStart Universal
SYBR Green Master (Roche), 4 μl of diluted DNA
and a final primer concentration depending on the
amplified pathogen (Table 2). Thermal cycling profile
was 50°C for 2 min and 95°C for 10 min, followed by
40 cycles at 95°C for 15 s and 60°C for 1 min. Speci-
ficity assessment of qPCR was performed by adding a
dissociation curve analysis at the end of the run. The
internal reference for cat genomic DNA was the
eukaryotic 18S RNA Pre-Developed TaqMan Assay
Reagents (Applied Byosystems), which ensured proper
qPCR amplification of each sample and that negative
results corresponded to true negative samples rather
than to a problem with DNA loading, sample degrad-
ation or PCR inhibition. Positive qPCR controls were
obtained from clinical samples previously amplified
and sequenced to confirm the pathogen. Water was
used as a negative control. The product of the real-
time PCR was sequenced with the BigDye Terminator
Cycle Sequencing Ready Reaction Kit (AB, Live Tech-
nologies) using the same primers. Sequences obtained
were compared with GenBank database (www.ncbi.
nlm.nih.gov/BLAST).
Statistical analysis
Prevalences of infection relative to the independent variables
(i.e. gender, age, breed, housing conditions, FeLV/FIV infec-
tions and clinical status) were compared by Chi-square or
Fisher’s exact tests. A p value < 0.05 was considered as






No. of positive cats (%)
Anaplasma/Ehrlichia B. canis B. vogeli H. felis L. infantum Rickettsia ≥1 agent(s)
Gender 320
Female 142 (44.4) 2 (1.4) 2 (1.4) 14 (9.9) 19 (13.4) 1 (0.7) 0 (0.0) 36 (25.4)
Male 178 (55.6) 0 (0.0) 2 (1.1) 12 (6.7) 31 (17.4) 0 (0.0) 4 (2.2) 44 (24.7)
Age (years) 312
[0.4-1.5] 90 (28.8) 0 (0.0) 2 (2.2) 11 (12.2)a 13 (14.4) 0 (0.0) 0 (0.0) 23 (25.6)
[2.0-6] 157 (50.3) 1 (0.6) 2 (1.3) 13 (8.3) 25 (15.9) 1 (0.6) 3 (1.9) 42 (26.8)
[7-20] 65 (20.8) 1 (0.6) 0 (0.0) 1 (1.5)a 11 (16.9) 0 (0.0) 1 (0.6) 14 (21.5)
Breed 320
DSH 274 (85.6) 2 (0.7) 4 (1.5) 19 (6.9) 43 (15.7) 1 (0.4) 3 (1.1) 66 (24.1)
Pure breed 46 (14.4) 0 (0.0) 0 (0.0) 7 (15.2) 7 (15.2) 0 (0.0) 1 (2.2) 14 (30.4)
Housing 316
Totally indoors 124 (39.2) 0 (0.0) 0 (0.0) 7 (5.6) 20 (16.1) 0 (0.0) 2 (1.6) 26 (21.0)
Outdoors access 192 (60.8) 2 (1.0) 4 (2.1) 19 (9.9) 30 (15.6) 1 (0.5) 2 (1.0) 54 (28.1)
FeLV 117
Negative 107 (91.5) 0 (0.0) 1 (0.9) 9 (8.4) 15 (14.0) 0 (0.0) 2 (1.9) 24 (22.4)
Positive 10 (8.5) 0 (0.0) 0 (0.0) 1 (10.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (10.0)
FIV 117
Negative 97 (82.9) 0 (0.0) 1 (1.0) 10 (10.3) 13 (13.4) 0 (0.0) 2 (2.1) 23 (23.7)
Positive 20 (17.1) 0 (0.0) 0 (0.0) 0 (0.0) 2 (10.0) 0 (0.0) 0 (0.0) 2 (10.0)
Clinical status 300
Non-suspect 132 (44.0) 2 (1.5) 2 (1.5) 16 (12.1) 17 (12.9) 1 (0.8) 1 (0.8) 34 (25.8)
Suspect 168 (56.0) 0 (0.0) 2 (1.2) 10 (6.0) 33 (19.6) 0 (0.0) 3 (1.8) 46 (27.4)
Total 320 (100) 2 (0.6) 4 (1.3) 26 (8.1) 50 (15.6) 1 (0.3) 4 (1.3) 80 (25.0)
ap = 0.031; B. canis: Babesia canis; B. vogeli: Babesia vogeli; DSH: domestic short-haired; FeLV: feline leukaemia virus; FIV: feline immunodeficiency virus; H. felis:
Hepatozoon felis; L. infantum: Leishmania infantum; PCR: polymerase chain reaction.
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SPSSW 11.5 software for Windows (SPSS Inc).
Results
Table 1 displays data on the prevalence of infection with
vector-borne agents among the 320 cats assessed in this
study. Cats (n = 312) were aged from 5 months to 20 -
years (mean: 4.32 years ± 3.88 standard deviation). Pure
breed cats were mainly Persians and Siamese. Absolute
numbers and proportions (positive/tested cats) of single
and co-infections are shown in Table 3.
Eighty cats (25.0%) were qPCR positive to at least one
of the tested agents, including seven (2.2%) cats co-
infected with two agents. Two cats (0.6%) were infected
with Anaplasma/Ehrlichia spp., four (1.3%) with B.
canis, 26 (8.1%) with B. vogeli, 50 (15.6%) with H. felis,
one (0.3%) with L. infantum and four (1.3%) with Rick-
ettsia spp. No cat tested positive to H. canis. One cat
(0.3%) was co-infected with B. canis and B. vogeli, three
(0.9%) with B. vogeli and H. felis, one (0.3%) with H. felisand L. infantum, and two (0.6%) with H. felis and Rick-
ettsia spp.
Sequencing confirmed B. canis in the one cat (100%
relatedness to GenBank HQ662634.1), B. vogeli in the
three cats (100% relatedness to GenBank JX871885.1)
and H. felis in the four cats (100% relatedness to
GenBank JQ867388.1) whose PCR products were se-
quenced. Because of the small quantities of amplified
bacterial DNA in the genus-specific PCR, additional
species-specific PCR assays or DNA sequencing were
not performed for those samples positive to genera
Anaplasma/Ehrlichia and Rickettsia.
A statistically significant difference (p = 0.031) was
found between the prevalence of infection with B. vogeli
in cats aged 5–18 months (0.42-1.5 years) and in cats
aged 7–20 years old (12.2% versus 1.5%, respectively)
(Table 1). No other significant differences were found
for the prevalence of infection with each vector-borne
agent, at least one agent (≥ 1 agent[s]) or co-infections
(2 agents), regarding all the independent variables.
Table 3 Prevalence of single and co-infections with
vector-borne pathogens in 320 cats from north and
centre Portugal, as determined by PCR
Agent(s) No. of positive cats %
Single infections 73 22.8
Anaplasma spp./Ehrlichia spp. 2 0.6
B. canis 3 0.9
B. vogeli 22 6.9
H. felis 44 13.8
L. infantum 0 0.0
Rickettsia spp. 2 0.6
Co-infections 7 2.2
B. canis + B. vogeli 1 0.3
B. vogeli + H. felis 3 0.9
H. felis + L. infantum 1 0.3
H. felis + Rickettsia spp. 2 0.6
Total 80 25.0
B. canis: Babesia canis; B. vogeli: Babesia vogeli; H. felis: Hepatozoon felis; L.
infantum: Leishmania infantum; PCR: polymerase chain reaction.
Table 2 Primer sequences of the tested vector-borne pathogens (genera or species)
Agents Amplified region Primer forward (5′-3′) Primer reverse (5′-3′) Final [primer]
(μM)
Anaplasma/Ehrlichia spp. 16S rRNA GGGTGAGTAATGCRTAGGAATCTACCTAGTA GGATTATACAGTATTACCCAYCATTTCTARTG 0.5
Babesia spp. 18S rRNA GTGGCTTTTCCGATTCGTCG TTCCTTTAAGTGATAAGGTTCACAAAACTT 0.3
Babesia canis 18S rRNA CGGTTTGACCATTTGGTTGGTTA CCATGCTGAAGTATTCAAGACAAAAGT 0.3
Babesia vogeli 18S rRNA CATTCGTTTGGCTTTTTCGAG CCATGCTGAAGTATTCAAGACAAAAGT 0.3
Hepatozoon felis 18S rRNA CTTACCGTGGCAGTGACGGT TGTTATTTCTTGTCACTACCTCTCTTATGC 0.3
Leishmania infantum kinetoplast DNA AACTTTTCTGGTCCTCCGGGTAG ACCCCCAGTTTCCCGCC 0.9
Rickettsia spp. 16S rRNA AGCCTGATCCAGCAATACCGA CGGGGCTTTTTCTGCAAGTAA 0.3
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The present study represents the most comprehensive
investigation on FVBD performed in Portugal, in terms
of the number of tested cats and extension of the cov-
ered geographical area, and reveals a considerable preva-
lence of infection in domestic cats from the north and
centre regions of Portugal. Anaplasma/Ehrlichia spp., B.
canis, B. vogeli, H. felis, L. infantum and Rickettsia spp.
were detected among the assayed feline population.
Several ehrlichial and rickettsial infections are shared by
man and companion animals [20]. In the present study,
Anaplasma/Ehrlichia spp. and Rickettsia spp. DNA were
detected in 0.6% and 1.3% of the cats, respectively. In cats
from southern Portugal, seroprevalences (by immuno-
fluorescence antibody tests) were 13.5% for Anaplasma
phagocytophilum and 18.9% for Rickettsia conorii [17],
and 26.3% for R. conorii/Rickettsia felis [19]. Furthermore,
Breu et al. [19] also reported feline infection by Ehrlichia
canis in Portugal. A national serological study on canine
vector-borne diseases in Portugal detected a significantly
higher seroprevalence of antibodies to Anaplasma spp.
and E. canis in dogs from southern Portugal, when com-
pared to dogs from the northern and central regions [7].
The present study represents the first report on the
prevalence of Babesia spp. in cats from Portugal. A higher
prevalence of Babesia spp. was found in Portuguese cats
(9.4%), in comparison with that detected in cats from
Barcelona, Spain (0/100) by Tabar et al. [12]. Interestingly,
it can also be presumed that the most prevalent piroplasm
in the Portuguese feline population is B. vogeli, instead of B.
canis, which was the piroplasm most frequently detected in
dogs with babesiosis from the north of Portugal [21]. So far,
feline infection with B. vogeli has only been described in
cats from Trinidad, Trinidad and Tobago [22], and
Bangkok, Thailand [23]. To the best of our knowledge, this
is the first time that infection with B. vogeli has been
detected in cats from Europe.
Feline co-infections with other erythrocytic pathogens
such as Mycoplasma spp., Cytauxzoon felis or other spe-
cies of Babesia may be possible [24,25]. In the present
study, only one cat was found co-infected with B. canis
and B. vogeli out of the 29 cats infected with Babesiaspp. Infection with B. canis and/or the Babesia microti-
like piroplasm (syn. Theileria annae) was previously
described in three cats from Portugal [26], but no infor-
mation is available on the geographical origin of those
cats. The B. microti-like piroplasm has also recently
been found in dogs from northern Portugal affected by
babesiosis [27]. In the present study, other species of the
genera Babesia and Theileria were not assessed. Never-
theless, as the entire results positive to the genus Babe-
sia had an assigned species (i.e. B. vogeli, B. canis or
both), although not impossible, a co-infection with the
B. microti-like piroplasm seems unlikely.
Age has been described as a predisposing factor for feline
infection with Babesia spp., with younger cats (less than 3 -
years old) more predisposed to infection in endemic areas
[24,28], and older cats more susceptible to the disease fol-
lowing relocation to an endemic area or in conjunction
with concurrent disease, immunosuppression or severe
trauma [24]. In the present study, juvenile cats (≤ 1.5 year)
had a significantly higher prevalence of B. vogeli infection
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cause of the less mature immune status of young cats.
Infection with Hepatozoon spp. is frequently reported in
dogs [29] but not in cats. Furthermore, the Hepatozoon
species that infect cats have not been definitely character-
ized [30,31]. Some authors have suggested that H. canis is
the agent responsible for feline infection, but a new, yet un-
named, species of Hepatozoon genetically distinct from H.
canis was recently detected in cats from southern and
northeastern Spain [30,32]. Infection with H. felis was
firstly described by Tabar et al. in cats from Barcelona [12].
This is also the first report of feline infection with H. felis
in Portugal. Molecularly confirmed infection with H. canis
in cats from southern Portugal [19] and in a dog from
northern Portugal [21] had already been described. The
detected 15.6% prevalence of infection with H. felis in the
present study is similar to that of Hepatozoon spp. (16%)
described by Ortuño et al. [30] in stray cats from Barcelona
(p = 0.960), but higher than the 0.6% of Hepatozoon spp.
found in Spanish domestic cats from a non-identified geo-
graphical background [32] and the 4.0% of H. felis in do-
mestic cats from Barcelona [12] (p < 0.001 and p = 0.002,
respectively). Moreover, the present study sustains the fact
that Hepatozoon infection is widespread in the feline popu-
lation of the Iberian Peninsula. Baneth et al. [33], in a study
from Israel, detected that most infected cats were young
domestic short-haired males and that there was an over-
representation of cats with retroviral disease. In the present
study, no statistically significant association was found be-
tween infection with H. felis and independent variables in-
cluding clinical status and FIV/FeLV infection (Table 1).
Leishmaniasis is an endemic zoonosis prevalent in the
Mediterranean basin [34,35]. The increase in the number
of infections and disease cases reported in recent years, to-
gether with the results described in different prevalence
studies, suggest that cats can act as a secondary reservoir
host instead of an accidental one in areas where Leish-
mania spp. are endemic [36-38]. Several surveys of Leish-
mania spp. infection in cats have been performed in
different countries by different techniques, with preva-
lences ranging between 0% and 68% [9,16,18,39-43]. In the
present study, detected prevalence (0.3%) might have been
different if the qPCR was carried out with another tissue
sample, such as bone marrow, spleen or liver. Results are
lower than the 2.8% seroprevalence (by the direct agglu-
tination test and an enzyme-linked immunosorbent assay)
found in cats from northern Portugal [18] and also lower
than the 20.3% obtained in blood samples from cats of
Greater Lisbon (southern-central Portugal) by PCR [16]
(p = 0.01 and p < 0.001, respectively). For the appropriate
agents under assessment in the present study, comparative
differences in the prevalence values can be related to dif-
ferent detection techniques (serology versus molecular
analysis) as well as to a different geographical origin ofcats (north and centre versus south). The latter may deter-
mine differences in climatic conditions, arthropod vector
survival and agent transmission rate.
Associations between housing conditions and preva-
lence of infection were not found among cats for any
one of the agents. Conversely, in a comparable study on
canine vector-borne diseases, also in Portugal, a signifi-
cantly higher sero-positivity to at least one agent (i.e.
Dirofilaria immitis, E. canis, Borrelia burgdorferi sensu
lato, Anaplasma spp. and/or L. infantum) has been
found in clinically suspect dogs with an outdoor or
mixed lifestyle [7].
Conclusions
In the north and centre regions of Portugal, a high
prevalence of infection with B. vogeli and H. felis, and a
relatively low prevalence of infection with Anaplasma/
Ehrlichia spp., B. canis, L. infantum and Rickettsia spp.
were found in cats. Further studies on these and other
vector-borne agents are needed to better understand
their epidemiological and clinical importance. It is also
necessary to call on veterinarians and owners to adopt
effective control measures, including chemoprophylaxis
against the ectoparasite vectors, in order to prevent in-
fection of cats with agents of FVBD and their potential
transmission to other domestic and wild animals as well
as to human beings.
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